What is the best pharmacologic treatment for sickle cell disease pain crises? （打开新窗口）

Baker M, Hafner JW.

来源‎: Ann Emerg Med 2012;59(6):515-6.

检索‎: PubMed 22221839

DOI码‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 （打开新窗口）

Update on pain management in sickle cell disease. （打开新窗口）

Ballas SK.

来源‎: Hemoglobin 2011;35(5-6):520-9.

检索‎: PubMed 21910604

DOI码‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 （打开新窗口）

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. （打开新窗口）

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

来源‎: Thromb Haemost 2007;98(2):392-6.

检索‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 （打开新窗口）

Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. （打开新窗口）

Tanabe P, Hafner JW, Martinovich Z, Artz N.

来源‎: Acad Emerg Med 2012;19(4):430-8.

检索‎: PubMed 22506947

DOI码‎: 10.1111/j.1553-2712.2012.01330.x

https://www.ncbi.nlm.nih.gov/pubmed/22506947 （打开新窗口）

Management of sickle cell disease. （打开新窗口）

de Montalembert M.

来源‎: BMJ 2008;337:a1397.

检索‎: PubMed 18779222

https://www.ncbi.nlm.nih.gov/pubmed/18779222 （打开新窗口）

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. （打开新窗口）

Okomo U, Meremikwu MM.

来源‎: Cochrane Database Syst Rev 2012;(6):CD005406.

检索‎: PubMed 22696351

DOI码‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 （打开新窗口）

Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. （打开新窗口）

Ip H, Kesse-Adu R, Howard J, Hart N.

来源‎: Br J Haematol 2013;161(3):455-6.

检索‎: PubMed 23419066

DOI码‎: 10.1111/bjh.12254

https://www.ncbi.nlm.nih.gov/pubmed/23419066 （打开新窗口）

Guidelines for the management of the acute painful crisis in sickle cell disease. （打开新窗口）

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

来源‎: Br J Haematol 2003;120(5):744-52.

检索‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 （打开新窗口）

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. （打开新窗口）

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

来源‎: Diving Hyperb Med 2012;42(2):82-4.

检索‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 （打开新窗口）

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. （打开新窗口）

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

来源‎: Hemoglobin 2004;28(2):85-102.

检索‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 （打开新窗口）

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. （打开新窗口）

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

来源‎: N Engl J Med 1995;333(11):699-703.

检索‎: PubMed 7637747

DOI码‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 （打开新窗口）

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. （打开新窗口）

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

来源‎: J Investig Med 2008;56(8):1023-7.

检索‎: PubMed 19050460

DOI码‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 （打开新窗口）

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. （打开新窗口）

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

来源‎: N Engl J Med 2000;342(25):1855-65.

检索‎: PubMed 10861320

DOI码‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 （打开新窗口）